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Abstract 
Background: One of the most common causes of hypothyroidism is Hashimoto s´ Thyroiditis (HT). Early detection 
of dry mouth is critical in preserving and promoting systemic and oral health.  In this study we have assessed, 
for the first time, salivary function and xerostomia in HT patients who have not been involved with Sjögren s´ 
syndrome.
Material and Methods: HT was diagnosed in 40 patients based on clinical findings and positive anti-thyroid per-
oxidase antibodies (anti-TPO). Controls, matched by sex, age and body mass index (BMI), and with no history of 
thyroid disease, were selected. 
A questionnaire was used for diagnosis of xerostomia. Saliva samples were taken between 8 a.m. and 9 a.m., and 
at least 2 hours after the last intake of food or drink. The flow rate was calculated in milliliters per minute. 
Results: Xerostomia was significantly higher in patients with HT. Unstimulated salivary flow rate was signifi-
cantly lower in the HT group. Stimulated salivary flow rate was lower in HT group, but the difference was not 
significant.
Conclusions: The patients with HT experienced xerostomia, and their salivary flow rate was diminished. Spitting 
the saliva then assessing salivary flow rate based on milliliter per minute is non-invasive, fast, and simple for 
chair-side diagnosis of dry mouth. Autoimmune diseases can be accompanied by salivary gland dysfunction. This 
may be due to the effect of cytokines in the autoimmune process or because of thyroid hormone dysfunctions.
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Introduction
One of the most common causes of hypothyroidism is 
Hashimoto’s Thyroiditis (HT), an autoimmune disease 
of the thyroid gland and a typical example of an organ-
specific autoimmune disorder (1,2).
Xerostomia and decreased salivary flow rate in HT is 
expected, even without association with Sjogren’s syn-
drome, for the following reasons: Sjogren’s syndrome 
and autoimmune thyroiditis, have many genetic and im-
munopathological similarities. They  have some features 
in common such as both are equally more common in 
females than in males, and the peak of prevalence oc-
curs between 30 and 50 years (3). Their immunopatho-
logical similarities include autoimmunity in epithelial 
cells, T lymphocytic infiltration, epithelial HLA class 
II molecules expression, clonally B expansion and the 
probability of developing mucosa-associated lymphoid 
tissue (MALT) lymphoma (3).
There are articles which credit salivary changes as a mir-
ror of the body, reflecting endocrine and other biological 
changes in patients with xerostomia (4,5), and one of the 
essential components in maintaining good oral hygiene is 
proper qualitative and quantitative saliva (6).
Oral hygiene has significant association with various 
diseases such as cardiovascular disease and airway in-
fection. Periodontal disease has been associated with 
the onset, progression, and severity of autoimmune dis-
orders. As cardiovascular disease and airway infection 
may increase morbidity in patients with autoimmune 
disease, good oral hygiene may have an important, posi-
tive influence (6).
The aim of this study is the evaluation of salivary func-
tion and xerostomia in Hashimoto patients who have not 
suffered from Sjögren s´ syndrome.
Material and Methods
Forty women from the outpatient unit of Arash Hos-
pital (Tehran University of Medical Sciences), and di-
agnosed with Hashimoto’s Thyroiditis, were enrolled 
in this study through convenience sampling (Fig. 1). 
Diagnosis was based on clinical findings and positive 
anti-thyroid peroxidase antibodies (anti-TPO). All pa-
tients were under thyroxine therapy and none of them 
was hypothyroid at the time of the study.  Thyroxine is 
not a xerogenic medication. 
Sex-, age-, and body mass index (BMI) frequency 
matched controls, with no history of thyroid disease, 
were selected. The controls were selected from the 
women staff of our department. Exclusion criteria were 
smoking, taking xerogenic medical agents, oral candid-
iasis or unfavorable oral health conditions (pocket depth 
more than 3 mm), history of head and neck radiation 
and diagnosis of an immunological disorder, diabetes, 
any infectious disease, any malignancy, or any other 
systemic disease.
Patient informed consent was obtained before com-
mencing the study, and the protocol was approved by 
the Ethics Committee of Tehran University of Medical 
Sciences, Iran.
The women in both groups were asked to complete a 
questionnaire that contains a list of symptoms associ-
ated with xerostomia (7,8). A second questionnaire 
was used to evaluate the severity of xerostomia (9,10). 
Xerostomia inventory (XI) score was defined as the se-
verity of dry mouth feeling (11). The response to each 
question was scored as follows: 1 = never, 2 = hardly, 3 
= occasionally, 4 = fairly often and 5 = very often. The 
score to all 11 questions were summed for each indi-
vidual. The range of XI scores was therefore 11 (11 × 1) 
to 55 (11 × 5).
Blood specimens were obtained from both groups to 
determine the presence of autoantibodies (anti-TPO, 
anti-thyroglobulin (Tg), anti-Ro/SSA, anti-La/SSB, au-
toantibodies to nucleus and anti-nature double-strand 
DNA).
We ruled out Sjogren’s syndrome in HT patients based 
on the 2012 American College of Rheumatology (ACR) 
Classification Criteria (11). Patients were assessed for 
two of three criteria: anti-Ro/SSA, anti-La/SSB and 
Keratoconjunctivitis sicca.  
WomenwithHTreferredfromApril2012to
January2013,withoutanyotheridentifieddisease
N=100
Enrolledinthestudy
N=40
Excluded:
Understeroidstherapy:N=7
Pregnantorbreastfeeding:N=11
Startedtouseneurologicdrugs:N=2
Unabletocontactorrefusetoparticipate:N=40
Fig. 1. Enrolled and excluded subjects.  
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- Saliva collection
Stimulated and unstimulated whole-saliva samples were 
taken under resting conditions in a quiet room between 8 
a.m. and 9 a.m., and at least 2 hours after the last intake 
of food or drink. Unstimulated salivary samples were 
obtained by expectoration without chewing movements. 
Subsequently, participants chewed a piece of paraffin of 
identical size. 60 seconds after pre-stimulation, the par-
ticipants were asked to swallow the saliva present in the 
mouth and then samples were obtained by expectora-
tion. Stimulated and unstimulated whole-saliva samples 
were collected in a calibrated and dry plastic tube. Sa-
liva was collected over a period of 5 minutes. The flow 
rate was calculated in milliliters per minute (4). 
- Statistical analysis
Statistical analysis was performed using SPSS version 
16 software. The normal distributions of continuous 
variables were assessed by the Kolomogrov-Smirnov 
test. The continuous variables are expressed as mean 
± S.D. or median (interquartile range) as appropriate, 
and categorical variables are expressed as a number 
(%). Student s´ t-test was used to compare mean values 
between groups where the distribution was normal, and 
Mann-Whitney non-parametric test was used when the 
distribution of values was not normal.
The odds ratio (OR) of each variable and the 95% con-
fidence intervals (CI) were calculated. The significance 
level (P value) for all of the analyses was defined as 
P<0.05. Binary logistic regression analysis was per-
formed to analyze the predictive value of parameters.
Results
The characteristics of case and control participants are 
shown in table 1. Subjects who had at least 3 positive 
responses to the questionnaire, with a list of symptoms 
associated with xerostomia formed the xerostomic in-
dividuals (5). Women with at least 3 positive responses 
were selected as xerostomic subjects, because some 
questions (questions 2 and 9) may be related to other 
disorders and are not specific to xerostomia. Six women 
in control and 16 women in HT group had xerostomia. 
So xerostomia was significantly higher in patients with 
HT. 
Mann–Whitney non parametric test showed that un-
stimulated salivary flow rate was significantly lower in 
HT group. (P < 0.05, Table 2). Stimulated salivary flow 
rate was lower in HT group, but the difference was not 
significant (Table 2). 
The value of unstimulated salivary flow rate as a pre-
dictor for the presence of HT was studied using logistic 
regression analysis. The adjusted OR for probability de-
crease of HT for 1 ml/min increase in salivary flow rate 
was 50 % (OR= 0.50, 95% CI: 0.30 - 0.84).
Xerostomia Inventory was increased in HT patients but 
it was not significant (P = 0.14).
The prevalence of Anti-TPO and Anti-Tg was 100% and 
40% in HT subjects, and 0% and 10% in controls re-
spectively. The results of other antibodies are shown in 
table 3. All patients were negative for anti-Ro/SSA and 
anti-La/SSB antibodies, and none of them had Kera-
toconjunctivitis sicca symptoms or positive responses 
Clinical characteristics                      Hashimoto women          Healthy women 
Age, y*                                                  39.20± 13.8                     38.95±14.2 
Menopause women                                       7                                       5 
Body mass index, kg/m2 *                    25.73 ± 3.82                    25.65 ± 3.95 
TSH, mIU/l                                             1.92±0.8                            2.67±1.3 
Women with xerostomia                         16(%40)                          6(%15)  a
Xerostomia Inventory *                        19.5 ± 11.25                       18 ± 9 
Table 1. Clinical characteristics and salivary flow rate of case and control participants. 
*  Data are expressed as mean ± SEM
a   P < 0.05.
P value CI ORControlMed (IQR)
Case
Med (IQR)
Parameters 
(ml/min) 
0.47 0.76-1.1 0.91 3.5(3.37) 2.87(3.29) Stimulated Flow Rate 
0.018* 0.3-0.85 0.5 2(2.14) 1.25(0.9) Unstimulated Flow Rate 
Table 2. Result of stimulated and unstimulated flow rates. 
Anti SSA,B Anti dsDNA ANA Anti-TgAnti-TPONumber Study group 
011164040Case
-004040Control
Table 3. Number of subjects with positive autoantibodies in case and control.
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to subjective symptoms related to Sjögren s´ syndrome 
(dryness feeling in eyes, lip and the nose - questions 9, 
10 and 11 of xerostomia Inventory). According to ACR 
criteria, participants with rheumatoid arthritis, systemic 
lupus erythematosus, scleroderma, or other connective 
tissue disease, were excluded. Also, only one patient 
was positive for ANA and anti dsDNA, which rules out 
the superimposition of other autoimmune connective 
tissue disorders. In fact we have excluded this important 
confounding factor.
Discussion
HT is a frequent form of autoimmune thyroid disease, 
affecting up to 2% of the general population; this is 
twice the prevalence of type 1 diabetes (12). 
In this study, in the absence of Sjogren syndrome, pa-
tients with HT experienced xerostomia and also had 
diminished salivary flow rate. Confounding factors 
such as menopause status, which is a xerogenic factor, 
had no effect on this result because there was no sig-
nificant difference between menopausal women in the 
two groups. The negative impact of hyposalivation on 
oral hygiene in patients with autoimmune diseases cer-
tainly increases morbidity in these patients. Therefore, 
salivary assessment for early detection of dry mouth is 
essential for maintaining and promoting systemic and 
oral health (6).
As Szanto A and his colleagues have suggested, autoim-
mune changes in endocrine glands such as thyroid, may 
also occur in exocrine glands such the salivary gland, 
because the process of both is secretion (13). These 
changes may occur in the salivary glands of HT patients 
too, and may cause salivary flow rate changes. 
Sjögren s´ syndrome is an autoimmune exocrinopathy 
often associated with Hashimoto s´ Thyroiditis, and the 
probability of this association will increase through 
time (3,13). Therefore one of the most important consid-
erations for a study on salivary changes in HT is ruling 
out Sjögren s´ syndrome in these patients.
To the best of our knowledge, there have been only two 
studies which assessed xerostomia and salivary flow 
rate in HT. Both had an identical method, and patients 
with autoimmune thyroiditis enrolled in the study had 
HT for 10 years. One of the most important limitations 
of those studies was the lack of Sjögren s´ syndrome ex-
clusion, especially after 10 years with HT (14,15). 
For the first time, we have assessed xerostomia, and 
stimulated and unstimulated whole salivary flow rate, 
in patients with HT not suffering from Sjögren s´ , based 
on ACR Classification Criteria (11). The diagnosis of 
dry mouth based on a minor salivary gland biopsy of 
the lips, Saxon test, sialography, and scintigraphy, re-
quires complex manipulation, takes a long time for di-
agnosis, and is invasive (6). Another advantage of our 
study, compared to previous studies, is the technique 
of salivary collection. Quantitating unstimulated and 
stimulated whole saliva flow rates (sialometry) is the 
most supported clinical method for diagnosing salivary 
gland dysfuncti (16) Spitting the  saliva then assessing 
salivary flow rate based on milliliter per minute is non-
invasive, fast, and simple for chair-side diagnosis of dry 
mouth.
The exact mechanism of impaired salivary secretion 
in autoimmune diseases other than Sjögren´ syndrome 
is not well understood, and studies based on salivary 
gland biopsy and radiological techniques may resolve 
this question (6).
The proposed mechanisms involved in the inhibition of 
the secretory process in these patients may be related to 
cytokines. Previous studies introduced interferon (IFN) 
as an independent factor influencing salivary gland 
function. They have shown that in different chronic in-
flammatory conditions, exposure of salivary glands to 
IFNs and proinflammatory cytokines such as IL6 in-
terferes with their ability to make saliva and this func-
tional loss was reversible and was independent from 
sialoadenitis or autoantibody production.  A complete 
recovery of salivary gland function was made by the 
removal of innate stimuli (17).
Both immune cells and thyroid cells themselves secrete 
IFN-γ in HT, and it may be responsible for the continu-
ation of the inflammatory process within the thyroid 
gland (18,19). So it could reasonably be proposed that 
IFNs are an important pathogenic factor in salivary 
gland hypofunction in HT.
IFNs can induce apoptosis, but the consensus from pre-
vious studies is that hypofunction is ‎not due to an in-
crease in apoptotic cell numbers in the glands. 
A suggested mechanism involved in IFN and IL-6-me-
diated salivary gland hypofunction is exposure of sali-
vary gland acinar cells to cytokines such as TNF-α and 
IFN-γ, which has been shown to disturb the integrity 
of tight junctions, thus causing disturbances in water 
transport (17). In various epithelia, cytokines are known 
to change epithelium integrity via alteration of junction 
proteins expression (19).
There are other salivary gland hypofunction mecha-
nisms in Sjögren s´ syndrome, consisting of:
1. Inhibition of neurotransmitter release by pro-inflam-
matory cytokines such as IL-1β, IL-6 and TNF-α (all of 
these cytokines are known to have a role in HT patho-
genesis).
2. Increased degradation of acetylcholine by cholinest-
erase (cholinesterase is increased in saliva and salivary 
glands of Sjögren s´ syndrome patients).
3. Glandular hypofunction by reducing the water con-
tent of saliva caused by blockage of muscarinic acetyl-
choline receptor M3.
4. Altered calcium signaling (19,20).
Each of these factors may contribute to hyposalivation 
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in other autoimmune diseases such as HT, therefore fur-
ther evaluations are necessary.
In a new animal study, tyrosylprotein sulfotransferase-2 
knockout mice have salivary hypofunction and smaller 
salivary gland size due to primary hypothyroidism. By 
thyroid hormone supplementation, all signs of hypothy-
roidism (serum T4 and body weight) and salivary gland 
hypofunction (histological changes and pilocarpine-
induced salivary flow) were restored to normal or near 
normal (21). We can conclude that in HT, the autoimmu-
nity process together with the role of thyroid hormones 
trophic effect on the salivary gland may induce salivary 
gland hypofunction. In our patients, thyroxine therapy 
restored thyroid function and they became euthyroid; 
but they had xerostomia because, while salivary chang-
es related to thyroxine function may have improved, 
there was no effect on possible autoimmune destruction 
of salivary glands. Further research may reveal if an im-
munosuppressant agent can alleviate salivary changes.  
In the current study, stimulated salivary flow rate was 
not significantly diminished in HT, so salivary stimu-
lation may relieve xerostomia in these patients. Man-
agement of xerostomia includes drug administration 
(systemic secretogogues, saliva substitutes and bile 
secretion stimulator), night guard, diet and habit modi-
fications, and salivary output stimulators like chew-
ing sugar-free, xylitol-containing mints, candies, and 
gum (22). One of the limitations of the current study 
is the limited follow-up with patients because of cross-
sectional study design. We suggest further longitudinal 
studies to evaluate salivary changes in HT.
Conclusion
Our data show that autoimmune diseases such as HT 
can be accompanied by salivary gland dysfunction, 
regardless of the absence of Sjögren s´ syndrome. This 
may be due to the effect of cytokines in the autoimmune 
process or because of thyroid hormone dysfunctions.
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